Wendy Guy
Founder at PROCESSA PHARMACEUTICALS, INC.
Net worth: 46 751 $ as of 31/03/2024
Profile
Wendy Guy is the founder of Processa Pharmaceuticals, Inc. where she currently holds the title of Chief Administrative Officer since 2017.
Ms. Guy is also the founder of Promet Therapeutics LLC.
Guy's former job includes being a Senior Manager-Business Operation at Questcor Pharmaceuticals, Inc. and a Senior Manager-US Operations at AGI Therapeutics Plc.
Guy's education history includes an undergraduate degree from Mount Wachusett Community College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
01/01/2024 | 19,768 ( 1.16% ) | 46 751 $ | 31/03/2024 |
Wendy Guy active positions
Companies | Position | Start |
---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Founder | 29/03/2011 |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Founder | - |
Former positions of Wendy Guy
Companies | Position | End |
---|---|---|
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Training of Wendy Guy
Mount Wachusett Community College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |
Processa Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Wendy Guy